Bruker price target lowered to $60 from $70 at Jefferies

Jefferies lowered the firm’s price target on Bruker (BRKR) to $60 from $70 and keeps a Buy rating on the shares. Although B2B was better than feared, the magnitude of the core growth reset and EPS were disappointing, especially given the chance to reset the bar more meaningfully coming out of Q1, the firm notes. Cost-outs should help 2026 EPS, and valuation remains attractive. However, Jefferies believes patience will be required as Bruker needs to rebuild credibility and return to a cadence of meeting or beating numbers.